Earth Science Tech Inc. (OTC: ETST) is positioning itself for growth by building a scalable, self-sustaining healthcare business through strategic acquisitions, end-to-end vertical integration, and a dual B2B and B2C revenue model. The company’s portfolio of pharmacies, telehealth platforms, and pharmaceutical distribution businesses connects patient consultations, clinical support, compounded medication production, and fulfillment, which helps streamline operations and control supply costs.
With its compounding pharmacies licensed across 34 U.S. jurisdictions, ETST is expanding its reach while generating both consumer-facing revenue and higher-margin business-to-business income from infrastructure and compounding services provided to third-party healthcare providers. This dual-market approach allows the company to capture value at multiple points in the healthcare delivery chain.
As ETST enters fiscal 2027, management plans to expand the geographic footprint of its subsidiaries and pursue strategic acquisitions and partnerships to support continued growth. The company’s principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. Its healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.
The core of ETST’s value proposition is the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries. For investors, the company’s focus on vertical integration and dual revenue streams could signal a resilient business model in the evolving healthcare sector. To view the full article, visit https://ibn.fm/vwtoj.
The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST. For more information about Earth Science Tech, visit www.EarthScienceTech.com.
InvestorWire, a specialized communications platform with a focus on advanced wire-grade press release syndication, is one of 75+ brands within the Dynamic Brand Portfolio @ IBN. The platform provides access to a vast network of wire solutions via InvestorWire to efficiently reach target markets, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, and a full array of tailored corporate communications solutions.
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer.
